National Healthcare (NHC) Fundamental Analysis: Revenue, Earnings & Valuation

8.19 / 10

Outperform

Fundamental analysis rates the stock Outperform with an 8.2/10 score. YoY profit growth is 19%, cash‑flow per share up 71.5%, and earnings per share rising over 17%. Asset‑to‑market and revenue‑to‑market ratios are favorable, while PB‑ROE remains modest.

Analysis Checks(8/10)

Revenue-MV

Value0.36

Score3/3

Weight25.23%

1M Return7.98%

Net cash flow from operating activities per share (YoY growth rate %)

Value71.52

Score3/3

Weight17.27%

1M Return5.35%

PB-ROE

Value0.32

Score1/3

Weight-0.98%

1M Return-0.34%

Basic earnings per share (YoY growth rate %)

Value17.22

Score2/3

Weight4.60%

1M Return1.70%

Total profit (YoY growth rate %)

Value19.08

Score2/3

Weight5.38%

1M Return1.87%

Net cash flow from operating activities (YoY growth rate %)

Value72.48

Score3/3

Weight17.61%

1M Return5.57%

Cash-UP

Value-1.60

Score0/3

Weight-11.01%

1M Return-4.87%

Diluted earnings per share (YoY growth rate %)

Value17.46

Score2/3

Weight3.36%

1M Return1.25%

Asset-MV

Value-0.55

Score3/3

Weight32.04%

1M Return9.13%

Cash-MV

Value-1.32

Score2/3

Weight6.51%

1M Return2.13%

Is NHC fundamentally strong?

NHC scores 8.19/10 on fundamentals and holds a Discounted valuation at present. Backed by its 11.67% ROE, 8.08% net margin, 20.46 P/E ratio, 2.28 P/B ratio, and 17.22% earnings growth, these metrics solidify its Outperform investment rating.